Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Cardiology

Building Your Care Team: Coordination and First Visit Prep

At a Glance

A coordinated team of heart, rhythm, genetics, and skin specialists is important for EKC syndrome. Before a specialty visit, gather the DSP genetic report, cardiac imaging and rhythm records, any biopsy report, medicines, symptoms, and family history; genetic counseling can guide family testing.

Because Erythrokeratodermia-cardiomyopathy (EKC) syndrome is so rare, your care cannot be managed by a single doctor. Success requires a multidisciplinary team—a group of specialists who look at your health from different angles but communicate as one unit [1][2].

Your Specialized Care Team

A comprehensive team for EKC should ideally include:

  • Inherited Cardiomyopathy Specialist: A cardiologist who understands the unique “left-dominant” or “biventricular” patterns of DSP-related disease [2][3].
  • Electrophysiologist (EP): A heart rhythm specialist who focuses on preventing and managing arrhythmias and making decisions about ICD placement [2].
  • Medical Geneticist & Genetic Counselor: These experts help interpret your specific mutation and manage the testing of your family members [4][1].
  • Dermatologist: Specifically one with experience in “genodermatoses” (genetic skin conditions) to manage the erythrokeratodermia and keratoderma [2].
  • Advanced Heart Failure Specialist: Should the heart’s pumping strength change, this specialist manages advanced medications and potential transplant evaluation [5].

Preparing for Your First Appointment

When you visit a specialty center, it is helpful to provide access to your full medical history. Secure electronic transfer directly between institutions is often the preferred option.

Your “First Visit” Artifact Checklist:

  • Full Genetic Laboratory Report: This must include the exact DSP variant (e.g., a specific “missense” or “nonsense” code), the pathogenicity classification (e.g., “Pathogenic” or “Likely Pathogenic”), and whether deletion/duplication analysis was performed [6][7].
  • Imaging Disks (DICOM files): If electronic transfer is not possible, bring the digital files of your Cardiac MRI (CMR) and Echocardiogram on a CD or USB drive, alongside the written reports.
  • ECG Tracings & Holter Reports: Bring the actual “squiggling line” printouts of your 12-lead ECGs and the full report of your 24-hour Holter monitor, especially the data on PVC burden and any NSVT [8][9].
  • Pathology Records: If you have had a skin biopsy, bring the written pathology report. A simple first-visit list of current medicines, symptoms, family history, and goals is also highly useful.

Cascade Testing: Protecting the Family

Inheritance patterns for DSP mutations can vary. Some are autosomal dominant (where a specific relative might have a 50% chance), some are recessive (biallelic), and others are de novo. A genetic counselor should calculate each relative’s risk from the exact report.

This is vital because DSP mutations can be “asymptomatic” or “phenotype-negative” [10][11]. A relative might have perfect heart function and clear skin today but still carry the risk of future heart issues [10]. In some families, the only clue might be woolly hair (unusually curly or coarse hair) or mild thickening of the skin on the feet [12][13]. However, even relatives with completely normal hair and skin can still have the underlying heart risk [14]. Relatives should first be offered counseling and targeted testing for a known pathogenic or likely pathogenic family variant. A relative who truly tests negative for the family’s pathogenic variant generally does not need ongoing DSP-specific cardiac surveillance, while a carrier may need a different plan.

Transitioning Care

If the patient is a child, it is never too early to discuss the pediatric-to-adult transition [1]. As adolescents grow, they will need to take over the management of their own appointments, genetic information, and reproductive counseling to understand the risks of passing the gene to the next generation [15][4]. Finding a center that manages both pediatric and adult cases can make this lifelong journey much smoother [16]. For adult patients, reproductive counseling is a key step before planning a family to discuss medication safety during pregnancy, the physical demands of pregnancy on the heart, and options for managing inherited risks.

Common questions in this guide

What specialists should be part of an EKC syndrome care team?
A coordinated team may include a cardiologist who treats inherited cardiomyopathy, an electrophysiologist for abnormal rhythms and ICD decisions, a medical geneticist or genetic counselor, and a dermatologist familiar with inherited skin disorders. An advanced heart failure specialist may join the team if the heart’s pumping strength changes.
What records should I bring to my first EKC appointment?
A complete DSP genetic report should show the exact variant, its classification, and whether deletion or duplication testing was done. Also bring cardiac MRI and echocardiogram images and reports, ECG and Holter results, any skin-biopsy report, and a current list of medicines, symptoms, family history, and goals.
Why do relatives need genetic counseling and targeted DSP testing?
DSP inheritance can be dominant, recessive, or new in the affected person, so a counselor must calculate risk from the family’s exact variant. Someone who carries the variant may have normal heart tests and skin at first, yet still face future heart risk; targeted testing can identify who needs follow-up.
Does a relative who tests negative for the family DSP variant need heart surveillance?
A person who truly tests negative for the known familial pathogenic or likely pathogenic DSP variant generally does not need ongoing DSP-specific cardiac surveillance. The family’s genetic counselor or cardiologist should confirm how the result applies to that person and whether another health concern calls for routine care.
How can children with EKC prepare to move from pediatric to adult care?
Transition planning should begin before the handoff so adolescents learn to manage appointments, genetic information, and questions about reproductive risks. A center that coordinates pediatric and adult heart, genetics, and skin care can make lifelong follow-up easier.

Get notified when new evidence is published on Erythrokeratodermia-cardiomyopathy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

    Hershberger RE, Givertz MM, Ho CY, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(9)):899-909 doi:10.1038/s41436-018-0039-z.

    PMID: 29904160
  2. 2

    Imaging Naxos disease and related cardiocutaneous syndromes: the NAXCARE multimodality approach.

    Protonotarios I, Alsergani H, Anastasakis A, et al.

    Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2026; doi:10.1016/j.hjc.2026.03.007.

    PMID: 41936932
  3. 3

    DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort.

    Di Lorenzo F, Marchionni E, Ferradini V, et al.

    International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24032490.

    PMID: 36768812
  4. 4

    The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.

    Cirino AL, Harris SL, Murad AM, et al.

    Journal of genetic counseling 2022; (31(6)):1290-1305 doi:10.1002/jgc4.1604.

    PMID: 35799446
  5. 5

    2020 Heart Failure Society of South Africa perspective on the 2016 European Society of Cardiology Chronic Heart Failure Guidelines.

    Hitzeroth J, Mpe M, Klug E, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2020; (110(8b)):13057.

    PMID: 32880257
  6. 6

    A Novel Heterozygous Desmoplakin Variant Causes Cardiocutaneous Syndrome with Arrhythmogenic Cardiomyopathy and Palmoplantar Keratosis.

    Çimen T, Medeiros-Domingo A, Kolios A, et al.

    Journal of clinical medicine 2023; (12(3)) doi:10.3390/jcm12030913.

    PMID: 36769561
  7. 7

    Recurrent myocarditis as a clinical gateway to desmoplakin cardiomyopathy: a case report.

    Reyes T RE, Vargas-Hernández DA, Cañón DP, Figueroa JF

    European heart journal. Case reports 2026; (10(3)):ytag062 doi:10.1093/ehjcr/ytag062.

    PMID: 41788433
  8. 8

    Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

    Smith E, Gasperetti A, Carrick RT, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.06.16.25329734.

    PMID: 40666337
  9. 9

    A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.

    Carrick RT, Gasperetti A, Protonotarios A, et al.

    European heart journal 2024; (45(32)):2968-2979 doi:10.1093/eurheartj/ehae409.

    PMID: 39011630
  10. 10

    Human Genetics of Cardiomyopathies.

    Houweling AC, Lekanne Deprez RH, Wilde AAM

    Advances in experimental medicine and biology 2024; (1441()):977-990 doi:10.1007/978-3-031-44087-8_63.

    PMID: 38884765
  11. 11

    Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy.

    Choi NH, Cherny S, Berul CI, et al.

    Circulation. Arrhythmia and electrophysiology 2024; (17(11)):e013114 doi:10.1161/CIRCEP.124.013114.

    PMID: 39523938
  12. 12

    Variant NAXOS-Carvajal Syndrome with Rare Additional Features of Systemic Bulla and Brittle Nails: A Case Report and Literature Review.

    Sato T, Okada S, Iwahana T, Kobayashi Y

    Internal medicine (Tokyo, Japan) 2021; (60(7)):1119-1126 doi:10.2169/internalmedicine.5899-20.

    PMID: 33132336
  13. 13

    DSP-palmoplantar epidermal differentiation disorder: a distinct phenotype and red flag for cardiomyopathy.

    Brandt E, Heliö K, Harjama L, et al.

    Clinical and experimental dermatology 2026; (51(2)):263-272 doi:10.1093/ced/llaf443.

    PMID: 41108751
  14. 14

    LV-predominant arrhythmogenic cardiomyopathy related to pathogenic DSP-variant.

    Ahmad S, El Sharu H, Fernandes R, et al.

    Clinical case reports 2024; (12(6)):e9003 doi:10.1002/ccr3.9003.

    PMID: 38827944
  15. 15

    Attitudes toward clinical genetic testing and data sharing among adolescents and young adults with congenital heart disease.

    Madanay F, Gutierrez AM, Nayan R, et al.

    Patient education and counseling 2026; (151()):109774 doi:10.1016/j.pec.2026.109774.

    PMID: 42462639
  16. 16

    Experience with genetic counseling: the adolescent perspective.

    Pichini A, Shuman C, Sappleton K, et al.

    Journal of genetic counseling 2016; (25(3)):583-95 doi:10.1007/s10897-015-9912-y.

    PMID: 26573304

This page is for informational purposes only and does not constitute medical advice. Your EKC cardiology, genetics, and dermatology team should interpret your records and make individualized decisions about testing and care.